Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Inhibition of HIV-1 replication by cell-penetrating peptides binding Rev.

Roisin A, Robin JP, Dereuddre-Bosquet N, Vitte AL, Dormont D, Clayette P, Jalinot P.

J Biol Chem. 2004 Mar 5;279(10):9208-14. Epub 2003 Dec 10.

2.

Inhibitors of HIV-1 gene expression and transcription.

Baba M.

Curr Top Med Chem. 2004;4(9):871-82. Review.

PMID:
15134546
3.

Role of viral regulatory and accessory proteins in HIV-1 replication.

Seelamgari A, Maddukuri A, Berro R, de la Fuente C, Kehn K, Deng L, Dadgar S, Bottazzi ME, Ghedin E, Pumfery A, Kashanchi F.

Front Biosci. 2004 Sep 1;9:2388-413. Review.

PMID:
15353294
4.

HIV-1 inactivation by nucleic acid aptamers.

Held DM, Kissel JD, Patterson JT, Nickens DG, Burke DH.

Front Biosci. 2006 Jan 1;11:89-112. Review.

PMID:
16146716
5.

Inhibition of HIV-1 replication by targeting the Rev protein.

Nakaya T, Iwai S, Fujinaga K, Otsuka E, Ikuta K.

Leukemia. 1997 Apr;11 Suppl 3:134-7. Review.

PMID:
9209321
6.

HIV-1 regulatory proteins: targets for novel drug development.

Ptak RG.

Expert Opin Investig Drugs. 2002 Aug;11(8):1099-115. Review.

PMID:
12150704
7.

Molecular biology of HIV-1: positive and negative regulatory elements important for virus expression.

Felber BK, Pavlakis GN.

AIDS. 1993;7 Suppl 1:S51-62. Review. No abstract available.

PMID:
8363803
8.

Controlling elements in replication of the human immunodeficiency virus type 1.

Li X, Quan Y, Wainberg MA.

Cell Mol Biol (Noisy-le-grand). 1997 May;43(3):443-54. Review.

PMID:
9193800
9.

HIV-1 auxiliary proteins: making connections in a dying cell.

Cullen BR.

Cell. 1998 May 29;93(5):685-92. Review. No abstract available.

10.

The HIV-1 Tat transactivator protein: a therapeutic target?

Fulcher AJ, Jans DA.

IUBMB Life. 2003 Dec;55(12):669-80. Review.

11.

Structural variety of membrane permeable peptides.

Futaki S, Goto S, Suzuki T, Nakase I, Sugiura Y.

Curr Protein Pept Sci. 2003 Apr;4(2):87-96. Review.

PMID:
12678848
12.

Discoveries of Tat-TAR interaction inhibitors for HIV-1.

Yang M.

Curr Drug Targets Infect Disord. 2005 Dec;5(4):433-44. Review.

PMID:
16535863
13.

Inhibitors of HIV-1 Tat-mediated transactivation.

Richter SN, Palù G.

Curr Med Chem. 2006;13(11):1305-15. Review.

PMID:
16712471
14.

Lessons from HIV: movement of macromolecules inside the cell.

Fackler OT, Peterlin BM, Weis K.

Curr Mol Med. 2001 Mar;1(1):1-7. Review.

PMID:
11899237
15.

Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy?

Richter SN, Frasson I, Palù G.

Curr Med Chem. 2009;16(3):267-86. Review.

PMID:
19149577
16.

[Mechanism of HIV replication].

Adachi A, Yamamoto Y, Sone S.

Uirusu. 1996 Dec;46(2):145-54. Review. Japanese. No abstract available.

17.

[Synthesis of biomimetic analogs of neomycin B].

Nishizono N.

Yakugaku Zasshi. 2002 Jul;122(7):465-9. Review. Japanese.

18.

Selection of HIV replication inhibitors: chemistry and biology.

Hwang S, Tamilarasu N, Rana TM.

Adv Pharmacol. 2000;49:167-97. Review. No abstract available.

PMID:
11013764
19.

HIV regulatory proteins: potential targets for therapeutic intervention.

Rosen CA.

AIDS Res Hum Retroviruses. 1992 Feb;8(2):175-81. Review.

PMID:
1540405
20.

Intracellular cargo delivery using tat peptide and derivatives.

Zhao M, Weissleder R.

Med Res Rev. 2004 Jan;24(1):1-12. Review.

PMID:
14595670

Supplemental Content

Support Center